Akebia Therapeutics (AKBA) Share-based Compensation (2015 - 2026)
Akebia Therapeutics' Share-based Compensation was $3.23 million in Q2 2026, up 20.6% from $2.68 million a year earlier but down 12.1% from the prior quarter.
Powered by 
Analysis
Akebia Therapeutics (AKBA) Share-based Compensation (2015 - 2026) Analysis & Trends
On a trailing twelve-month basis, Akebia Therapeutics' Share-based Compensation was $13.31 million through Jun 30, 2026, up 62.2% year-over-year; for FY2025, it was $11.28 million, up 45.1% from FY2024.
- Share-based Compensation shows a five-year compound annual growth rate of -14.3% (FY2020 to FY2025).
- In earlier years, Share-based Compensation was $7.78 million in FY2024 (-16.6%), $9.32 million in FY2023 (-47.8%), $17.85 million in FY2022 (-21.5%) and $22.74 million in FY2021 (-7.1%).
- Quarterly Share-based Compensation has moved between $1.51 million (Q4 2023) and $6.92 million (Q2 2022) over five years.
- Compared with a year earlier, Share-based Compensation has increased for five straight quarters, with growth averaging 37.1% over the last eight quarters.
- The best year-over-year quarter for Share-based Compensation over five years was Q3 2025 (growth of 95.7%); the worst was Q4 2023 (a decline of 50.2%).
- Per Business Quant data, AKBA's Share-based Compensation in the three quarters before Q2 2026 was $3.67 million (Q1 2026), $3.2 million (Q4 2025) and $3.22 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Akebia Therapeutics | 241.85 Mn | -427.63 Mn | 38.70 Mn | 3.23 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.23 Mn |
| Mar 31, 2026 | 3.67 Mn |
| Dec 31, 2025 | 3.20 Mn |
| Sep 30, 2025 | 3.22 Mn |
| Jun 30, 2025 | 2.68 Mn |
| Mar 31, 2025 | 2.19 Mn |
| Dec 31, 2024 | 1.70 Mn |
| Sep 30, 2024 | 1.65 Mn |
| Jun 30, 2024 | 2.07 Mn |
| Mar 31, 2024 | 2.36 Mn |
| Dec 31, 2023 | 1.51 Mn |
| Sep 30, 2023 | 1.82 Mn |
| Jun 30, 2023 | 3.49 Mn |
| Mar 31, 2023 | 2.49 Mn |
| Dec 31, 2022 | 3.04 Mn |
| Sep 30, 2022 | 3.36 Mn |
| Jun 30, 2022 | 6.92 Mn |
| Mar 31, 2022 | 4.54 Mn |
| Dec 31, 2021 | 4.64 Mn |
| Sep 30, 2021 | 5.59 Mn |
API Access
Akebia Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=AKBA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "AKBA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=AKBA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();